# LAMIVUDINE AND ZIDOVUDINE
> **ANDA206375** · Abbreviated New Drug Application (Generic) · Sponsor: EPIC PHARMA LLC · Approved 2018-04-10
## Drug
- **FDA Application Number:** ANDA206375
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE AND ZIDOVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; ZIDOVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EPIC PHARMA LLC
- **First approval:** 2018-04-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206375)
---
*AI Analytics · CC0 1.0*